Medtronic patent exec Ruschke nominated to lead PTAB
As chief patent counsel at Medtronic, Rushke managed numerous patent appeals, interferences, post grant reviews and inter partes reviews, the U.S. Patent and Trademark Office said.
“The Patent Trial and Appeal Board plays a critical role in the patent ecosystem, especially since the launch of post-grant trials authorized in the America Invents Act of 2011. David’s breadth of experience in global patent opposition proceedings and his deep understanding of intellectual property positions him perfectly to lead our Board well into the future,” U.S. PTO Director Michelle Lee said in prepared remarks.
Registration is open for DeviceTalks Boston! Join us on June 5-6, 2019, as we explore the trends and technology that are shaping the future of the medical device industry.